Catalyst Wire Dossier Catalyst Wire Dossier

GS-9131

· Gilead Sciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS-9131, covering 2021-01-05 to 2021-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy of GS-9131 Functional Monotherapy in Human Immunodeficiency Virus (HIV)-1-Infected Adults Failing a Nucleos(t)Ide Reverse Transcriptase Inhibitor-Containing Regimen With Nucleos(t)Ide Reverse Transcriptase Inhibitor Resistant Virus [Phase 2]

See pricing